The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Pacific Biosciences of California Inc. (PACB) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.03, or 0.24%, to $12.70. The Pacific Biosciences of California Inc. has recorded 385,301 volume in the after hours trading session. Most recently, Yahoo Finance reported about the stock as it publicized that PacBio to Present at BofA Securities 2023 Health Care Conference.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
The company is listed on the NASDAQ and operates within the Medical Devices industry segment. At the end of the last regular session, the stock closed at $12.67 and fluctuated between $12.81 as its day high and $12.40 as its day low. The current market capitalization of Pacific Biosciences of California Inc. is $3.17B. A total of 2.38 million shares were traded on the day, compared to an average of 3.66M shares.
Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, PACB has seen 6 BUY and 5 SELL insider trades, representing the acquisition of 1,328,687 and the disposition of 35,776 shares. Over the last 12 months, there were 9 BUYs and 11 SELLs from insiders. Insiders purchased 1,963,687 shares during that period but sold 214,210.
In the most recent transaction, Farmer Michele sold 5,165 shares of PACB for 12.59 per share on May 18. After the transaction, the insider now owns 107,577 company shares. In a previous transaction on Mar 15, Ericson William W. sold 7,541 shares at 8.90 per share. PACB shares that Director owns now total 18,795.
Among the insiders who sold shares, HENRY CHRISTIAN O disposed of 13,769 shares on Mar 03 at a per-share price of $9.49. This resulted in the insider holding 1,222,939 shares of PACB after the transaction. In another insider transaction, Van Oene Mark sold 6,268 shares at $9.49 per share on Mar 03. Company shares held by the insider now total 965,871.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for PACB in the last 3 months, the mean price target is $13.80 with high estimates of $17.00 and low estimates of $12.00. In terms of 52-week highs and lows, PACB has a high of $14.20 and a low of $3.85.
As of this writing, PACB has an earnings estimate of -$0.32 per share for the current quarter. EPS was calculated based on a consensus of 9 estimates, with a high estimate of -$0.28 per share and a lower estimate of -$0.36. The company reported an EPS of -$0.37 in the last quarter, which was -2.80% lower than expectations of -$0.36.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. PACB’s latest balance sheet shows that the firm has $1.04B in Cash & Short Term Investments as of fiscal 2021. There were $953.75M in debt and $83.29M in liabilities at the time. Its Book Value Per Share was $2.86, while its Total Shareholder’s Equity was $790.99M.
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PACB is Buy with a score of 3.89.